Proacta S.A. (WSE:PAC)

Market Cap	219.58M +127.9%
Revenue (ttm)	6.54M +164.8%
Net Income	-4.99M
EPS	-0.04
Shares Out	117.43M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,934
Open	2.020
Previous Close	1.960
Day's Range	1.810 - 2.020
52-Week Range	0.660 - 2.720
Beta	1.23
Analysts	n/a
Price Target	n/a
Earnings Date	May 12, 2026

About Proacta

Proacta S.A. develops and provides IT solutions. The company specializes in artificial intelligence, bioinformatics, and advanced medical and genetic data analysis. The company offers Dbam o siebie Smart LAB, a platform that generates personalized reports based on laboratory test results; DBCU, an innovative platform using advanced technologies to optimize the breast cancer treatment process; and Patient Portal, an innovative tool for monitoring health, managing medical data, and supporting the treatment process. It also provides AI/ML services...

• Industry: Computer Programming, Data Processing, And Other Computer Related Services
• Founded: 2015
• Employees: 14
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: PAC

Financial Performance

In 2024, Proacta's revenue was 3.12 million, an increase of 380.99% compared to the previous year's 647,669. Losses were -9.54 million, 862.8% more than in 2023.